These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21955541)

  • 1. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
    Shen Y; Wang J; Qi T; Wang Z; Lu H
    Int J STD AIDS; 2014 Jun; 25(7):504-10. PubMed ID: 24327726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
    Duber HC; Dansereau E; Masters SH; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masiye F; Njuguna P; Odeny T; Okiro E; Roberts DA; Gakidou E
    PLoS One; 2015; 10(3):e0120350. PubMed ID: 25807553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic-based observational cohort study in four African countries.
    Esber AL; Coakley P; Ake JA; Bahemana E; Adamu Y; Kiweewa F; Maswai J; Owuoth J; Robb ML; Polyak CS; Crowell TA;
    J Int AIDS Soc; 2020 Feb; 23(2):e25446. PubMed ID: 32064776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.
    French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D;
    HIV Clin Trials; 2002; 3(3):177-85. PubMed ID: 12032876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
    Castelnuovo B; Kiragga A; Kamya MR; Manabe Y
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):59-63. PubMed ID: 20861741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends Over Time for Adolescents Enrolling in HIV Care in Kenya, Tanzania, and Uganda From 2001-2014.
    Apondi E; Humphrey JM; Sang E; Mwangi A; Keter A; Musick BS; Nalugoda FK; Ssali J; Bukusi E; Yiannoutsos CT; Wools-Kaloustian K; Ayaya S
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):164-172. PubMed ID: 29985263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.
    Mullin S; Temu A; Kalluvya S; Grant A; Manji H
    Trop Med Int Health; 2011 Oct; 16(10):1291-6. PubMed ID: 21707880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine.
    Mudiope PK; Kim S; Wabwire D; Nyende L; Bagenda D; Mubiru M; Mulira R; Elbireer S; Namukwaya Z; Fowler MG; Musoke P
    Trop Med Int Health; 2013 Mar; 18(3):344-51. PubMed ID: 23289497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reviewing progress: 7 year trends in characteristics of adults and children enrolled at HIV care and treatment clinics in the United Republic of Tanzania.
    Nuwagaba-Biribonwoha H; Kilama B; Antelman G; Khatib A; Almeida A; Reidy W; Ramadhani G; Lamb MR; Mbatia R; Abrams EJ;
    BMC Public Health; 2013 Oct; 13():1016. PubMed ID: 24160907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.
    Gunda DW; Godfrey KG; Kilonzo SB; Mpondo BC
    Malawi Med J; 2017 Mar; 29(1):43-52. PubMed ID: 28567196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
    Hawkins C; Christian B; Ye J; Nagu T; Aris E; Chalamilla G; Spiegelman D; Mugusi F; Mehta S; Fawzi W
    AIDS; 2013 Mar; 27(6):919-927. PubMed ID: 23196935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study.
    Anekthananon T; Ratanasuwan W; Techasathit W; Sonjai A; Suwanagool S
    J Med Assoc Thai; 2004 Jul; 87(7):760-7. PubMed ID: 15521230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.